enGene Therapeutics (ENGN) Q1 2025 Earnings

Mar 10Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.48
-0.41
-0.33
-0.26

Details

Expected EPS
-0.367786
Actual EPS
-0.48
Surprise EPS
-0.11
Surprise Percent
-30.51%

Description

⁨enGene Therapeutics⁩ (⁦ENGN⁩) has reported earnings of ⁦-0.48⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts